« Back
Home /
Adavosertib（MK-1775）

Adavosertib（MK-1775）

Item no.	M2143-5mg
Manufacturer	AbMole
CASRN	955365-80-7
Amount	5mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Colorectal Cancer
Type	Inhibitors
Specific against	other
Purity	0,9989
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	AZD1775
Similar products	MK-1775
Available
Molecular Weight	500, 61
Solubility	DMSO 70 mg/mL
Bioactivity information	Adavosertib (AZD1775, MK-1775) is a small pyrazolacil derivative, an effective ATP competitive specific inhibitor of WEE1 kinase, with IC50 of 5.2 nM. It can inhibit G2 phase DNA damage test sites.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M2143-5mg-safety-datasheet.pdf